Design of Antigenically-Specific Probes for Sera Analysis and MAb Isolation
用于血清分析和单克隆抗体分离的抗原特异性探针的设计
基本信息
- 批准号:8556160
- 负责人:
- 金额:$ 9.9万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:AdsorptionAntibodiesAntibody FormationAntigensB-LymphocytesBindingBioinformaticsBiologicalBiological AssayComputational BiologyDevelopmentElementsEpitopesEvaluationGenesGoalsHIV-1Immune systemIndividualInfectionPatientsPlayProcessProteinsRoleSerologic testsSerumSolutionsSpecificityStructureSurfaceTechniquesTherapeuticVaccinesVariantbasecomputerized toolsdesignenv Glycoproteinsflexibilityinsightneutralizing antibodynext generationnovelphysical propertyresearch studyresponsestructural biologytool
项目摘要
An understanding of the serum responses of both HIV-1-infected individuals and vaccines is necessary for the development of an effective HIV-1 vaccine. Perhaps the most important biological aspect of a serum response is its neutralizing activity, with a close second being a compendium of its antigenic recognition. We will utilize the tools of structural and computational biology to develop probes to assist in the evaluation of the neutralizing activity of sera, and to decipher the HIV-1 elements recognized by both binding and neutralizing antibodies. Further, these probes will be used for the selection and isolation of B-cells so that their antibody gene loci can be sequenced, enabling the in-depth characterization of secreted antibodies. These capabilities are expected to enhance our understanding of how a broadly neutralizing antibody response develops during the course of infection and also of how the humoral immune system targets vulnerable regions on the HIV-1 Env glycoprotein.
The tools of computational design allow for the manipulation of both the surface of a protein as well as its interior. Surface manipulation allows for a precise control of antigenicity, whereas interior manipulation allows for physical properties of flexibility and stability to be altered, thereby modulating surface antigencity. Together these tools should allow for a precise understanding of elicited serum responses. Such an understanding should facilitate the iterative structure-based improvement of immunogens.
The next-generation sequencing technique, 454 pyrosequencing, allows hundreds of thousands of antibody sequences to be obtained directly from patient sera, thus enabling quantitative analysis of serum response, better understanding of antibody maturation process, and identification of broadly neutralizing antibodies. Due to the natural variation of antibody sequences and inherent sequencing errors, novel bioinformatics techniques have to be developed for antibodyome analysis. These techniques will play a critical role in sera analysis and antibody identification. Identified antibodies can represent natural solutions to antibody optimization, which has potential implications for therapeutic and/or passive transfer studies.
了解HIV-1感染者和疫苗的血清反应对于开发有效的HIV-1疫苗是必要的。也许血清反应最重要的生物学方面是它的中和活性,其次是它的抗原识别概要。我们将利用结构生物学和计算生物学的工具来开发探针,以辅助评估血清的中和活性,并破译结合抗体和中和抗体识别的HIV-1元件。此外,这些探针将用于B细胞的选择和分离,以便对它们的抗体基因位点进行测序,从而能够深入表征分泌的抗体。这些能力有望增强我们对感染过程中如何产生广泛的中和抗体反应,以及体液免疫系统如何针对HIV-1包膜糖蛋白上的脆弱区域的了解。
计算设计的工具允许操控蛋白质的表面和内部。表面操纵允许精确控制抗原性,而内部操纵允许改变柔韧性和稳定性的物理属性,从而调节表面抗原性。这些工具结合在一起,应该可以精确地理解引起的血清反应。这样的理解应该有助于免疫原基于迭代结构的改进。
新一代测序技术454焦磷酸测序技术允许直接从患者血清中获得数十万个抗体序列,从而能够对血清反应进行定量分析,更好地了解抗体成熟过程,并识别广泛的中和抗体。由于抗体序列的自然变异和固有的测序错误,必须开发新的生物信息学技术来进行抗体组分析。这些技术将在血清分析和抗体鉴定中发挥关键作用。识别的抗体可以代表抗体优化的自然解决方案,这对治疗性和/或被动转移研究具有潜在的意义。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Peter D Kwong其他文献
Design clues from functional constraints and broadly neutralizing antibodies
- DOI:
10.1186/1742-4690-3-s1-s22 - 发表时间:
2006-12-21 - 期刊:
- 影响因子:3.900
- 作者:
Tongqing Zhou;Ling Xu;Barna Dey;Ann J Hessell;Shahzad Majeed;Donald Van Ryk;Shi-Hua Xiang;Xinzhen Yang;Mei-Yun Zhang;Michael B Zwick;James Arthos;Dennis R Burton;Dimiter S Dimitrov;Joseph Sodroski;Richard Wyatt;Gary J Nabel;Peter D Kwong - 通讯作者:
Peter D Kwong
Peter D Kwong的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Peter D Kwong', 18)}}的其他基金
CAPRISA HIV-1 neutralizing antibodies: Harnessing ontogeny for immunogen design
CAPRISA HIV-1 中和抗体:利用个体发育进行免疫原设计
- 批准号:
9197956 - 财政年份:2015
- 资助金额:
$ 9.9万 - 项目类别:
Computational Tools for Protein Crystallization and Structural Analysis
蛋白质结晶和结构分析的计算工具
- 批准号:
10497779 - 财政年份:
- 资助金额:
$ 9.9万 - 项目类别:
Neutralization Mechanisms Of Anti-HIV-1 Monoclonal Antibodies
抗 HIV-1 单克隆抗体的中和机制
- 批准号:
8556097 - 财政年份:
- 资助金额:
$ 9.9万 - 项目类别:
Computational Tools for Protein Crystallization and Structural Analysis
蛋白质结晶和结构分析的计算工具
- 批准号:
8946617 - 财政年份:
- 资助金额:
$ 9.9万 - 项目类别:
Computational Tools for Protein Crystallization and Structural Analysis
蛋白质结晶和结构分析的计算工具
- 批准号:
8336700 - 财政年份:
- 资助金额:
$ 9.9万 - 项目类别:
相似海外基金
University of Aberdeen and Vertebrate Antibodies Limited KTP 23_24 R1
阿伯丁大学和脊椎动物抗体有限公司 KTP 23_24 R1
- 批准号:
10073243 - 财政年份:2024
- 资助金额:
$ 9.9万 - 项目类别:
Knowledge Transfer Partnership
Role of Natural Antibodies and B1 cells in Fibroproliferative Lung Disease
天然抗体和 B1 细胞在纤维增生性肺病中的作用
- 批准号:
10752129 - 财政年份:2024
- 资助金额:
$ 9.9万 - 项目类别:
CAREER: Next-generation protease inhibitor discovery with chemically diversified antibodies
职业:利用化学多样化的抗体发现下一代蛋白酶抑制剂
- 批准号:
2339201 - 财政年份:2024
- 资助金额:
$ 9.9万 - 项目类别:
Continuing Grant
Isolation and characterisation of monoclonal antibodies for the treatment or prevention of antibiotic resistant Acinetobacter baumannii infections
用于治疗或预防抗生素耐药鲍曼不动杆菌感染的单克隆抗体的分离和表征
- 批准号:
MR/Y008693/1 - 财政年份:2024
- 资助金额:
$ 9.9万 - 项目类别:
Research Grant
Developing first-in-class aggregation-specific antibodies for a severe genetic neurological disease
开发针对严重遗传神经系统疾病的一流聚集特异性抗体
- 批准号:
10076445 - 财政年份:2023
- 资助金额:
$ 9.9万 - 项目类别:
Grant for R&D
Discovery of novel nodal antibodies in the central nervous system demyelinating diseases and elucidation of the mechanisms through an optic nerve demyelination model
发现中枢神经系统脱髓鞘疾病中的新型节点抗体并通过视神经脱髓鞘模型阐明其机制
- 批准号:
23K14783 - 财政年份:2023
- 资助金额:
$ 9.9万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanisms controlling the physicochemical properties and functions of supercharged antibodies and development of their applications
阐明控制超电荷抗体的理化性质和功能的机制及其应用开发
- 批准号:
23KJ0394 - 财政年份:2023
- 资助金额:
$ 9.9万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Role of antibodies in hepatitis E virus infection
抗体在戊型肝炎病毒感染中的作用
- 批准号:
10639161 - 财政年份:2023
- 资助金额:
$ 9.9万 - 项目类别:
Defining the protective or pathologic role of antibodies in Post-Ebola Syndrome
定义抗体在埃博拉后综合症中的保护或病理作用
- 批准号:
10752441 - 财政年份:2023
- 资助金额:
$ 9.9万 - 项目类别:
Human CMV monoclonal antibodies as therapeutics to inhibit virus infection and dissemination
人 CMV 单克隆抗体作为抑制病毒感染和传播的治疗药物
- 批准号:
10867639 - 财政年份:2023
- 资助金额:
$ 9.9万 - 项目类别: